BRAF and thyroid gland carcinoma: In melanoma but not thyroid cancer, BRAF V600E mutation is associated with increased expression of VEGF and HIF1a. Taken together, the results shown here indicate that although the BRAF V600E mutation is present in both thyroid and melanoma cases, the link between mutation and the MPAS and BRAF expression are quite different.